MP
Matthew Pugh

Well Cited

71
Works
679
Citations
16
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Matthew Pugh

Also known as: M Pugh, M. R. Pugh, Matt Pugh, Matthew Pugh, Matthew R Pugh

71

Total Works

679

Citations

16

H-Index

18

i10-Index

Citation & Works Trend by Year
10 years active
Top Research Topics
Cancer Immunotherapy and Biomarkers (26) T-cell and B-cell Immunology (22) Pancreatic and Hepatic Oncology Research (21) Lymphoma Diagnosis and Treatment (16) Viral-associated cancers and disorders (14)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Dasatinib is a novel therapy for SRC-related thrombocytopenia University of Birmingham Research Portal (University of Birmingham) 0
2026 OC 57.5 Dasatinib is a novel treatment for patients with SRC-related thrombocytopenia Research and Practice in Thrombosis and Haemostasis 0
2026 Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma Leukemia 0
2026 WED-324-YI Human liver spatial transcriptomics reveals macrophage-driven antiviral responses distinguishing seronegative fulminant hepatitis from autoimmune hepatitis Journal of Hepatology 0
2026 Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of EBV + diffuse large B-cell lymphoma bioRxiv (Cold Spring Harbor Laboratory) 0
2026 Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury EBioMedicine 2
2025 Figure 1 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Figure 2 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Figure 4 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Figure 5 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Figure 6 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Figure 3 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Supplementary Fig. S1 - S12 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Supplementary Tables S1 - S5 from Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade 0
2025 Spatial transcriptomics links hepatocyte-macrophage interactions to viral signatures in seronegative hepatitis Research Square 0

Data source: OpenAlex API